A 20-patient study showed its ultrasound PAD balloon was effective in patients with arterial blockage below the knee.
Israeli diagnostics player MeMed reported data showing its blood test can accurately tell the difference between a bacterial and a viral infection.
A smartphone app, a pair of glasses and a 3D-printed box could spot jaundice, an early symptom of pancreatic cancer.
The Philips-HeartFlow deal follows earlier agreements with GE Healthcare and Siemens Healthineers.
SetPoint Medical rounded up $30 million, which will bankroll a phase 2 trial of its bioelelectronic therapy for rheumatoid arthritis.
Liquid biopsy player Exosome Diagnostics is partnering with CareFirst to create evidence development studies for the evaluation of its EvoDx tests.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a nanosystem that uses "quantum dots" to improve the imaging of human…
The appointment of Churcher as VP of drug discovery furthers the secretive AI-enabled startup’s track record of poaching execs from Big Pharma.
IBM and JDRF will use machine learning to identify risk factors that cause the onset of Type 1 diabetes in children.
Tandem started a pivotal trial of a system that automatically stops insulin delivery when a patient’s blood glucose levels are predicted to fall.